What is Borregaard ASA?
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally.
0QB7 · Verdict
Solid reward · low risk
0QB7 stands out on balance sheet and volatility, but watch the cash flow signal.
Based on 75% data coverage
0QB7 · Verdict
Current ratio 1.46
Top decile vs peers
3% return on equity
Below average
Model-based scoring. For information only — not financial advice.
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company is listed on the LSE in UK, with a market capitalisation of 20.70B.
The scoring profile indicates moderate reward potential, with profitability and valuation as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.